首站-论文投稿智能助手
典型文献
The role of sphingosine-1-phosphate in bone remodeling and osteoporosis
文献摘要:
Osteoporosis is a systemic bone disease that affects more than 200 million people worldwide and is caused by the disruption of the equilibrium between osteoclastic bone resorption and osteoblastic bone formation.Sphingosine-1-phosphate(S1P)is a natural,bioactive sphingolipid that has been shown to play a major role in cardiovascular and immunological pathologies by regulating biological and cellular processes,including migration,differentiation,proliferation and survival.Recent studies also suggest a central role for S1 P in bone diseases,including osteoporosis;however,the effects of S1 P,particularly in bone metabolism,remain to be further elucidated.In this review,we summarize the available literature on the role of S1P in bone metabolism with a focus on osteoporosis.On the cellular level,S1P acts as an osteoclast-osteoblast coupling factor to promote osteoblast proliferation and bone formation.Moreover,the recruitment of osteoclast precursors to resorption sites is regulated by the interplay of S1P gradients and S1P receptor expression.From a clinical perspective,increasing evidence suggests that systemically elevated S1P blood levels may serve as an independent risk factor for osteoporosis-related fractures.Taken together,S1P signaling is a potential therapeutic target and may serve as a novel biomarker in patients with systemic bone disease.
文献关键词:
作者姓名:
Justus M.Grewe;Paul-Richard Knapstein;Antonia Donat;Shan Jiang;Daniel J.Smit;Weixin Xie;Johannes Keller
作者机构:
Department of Trauma and Orthopedic Surgery,University Medical Center Hamburg-Eppendorf,20246 Hamburg,Germany;Clinic and Polyclinic for Vascular Medicine,University Heart Center Hamburg-Eppendorf,20246 Hamburg,Germany;Institute of Biochemistry and Signal Transduction,University Medical Center Hamburg-Eppendorf,20246 Hamburg,Germany
引用格式:
[1]Justus M.Grewe;Paul-Richard Knapstein;Antonia Donat;Shan Jiang;Daniel J.Smit;Weixin Xie;Johannes Keller-.The role of sphingosine-1-phosphate in bone remodeling and osteoporosis)[J].骨研究(英文版),2022(02):265-273
A类:
osteoclastic
B类:
role,sphingosine,phosphate,bone,remodeling,osteoporosis,Osteoporosis,that,affects,more,than,million,people,worldwide,caused,by,disruption,equilibrium,between,resorption,osteoblastic,formation,Sphingosine,S1P,natural,bioactive,sphingolipid,has,been,shown,major,cardiovascular,immunological,pathologies,regulating,biological,cellular,processes,including,migration,differentiation,proliferation,survival,Recent,studies,also,central,diseases,however,effects,particularly,metabolism,remain,further,elucidated,In,this,review,summarize,available,literature,focus,On,acts,coupling,promote,Moreover,recruitment,precursors,sites,regulated,interplay,gradients,receptor,expression,From,clinical,perspective,increasing,evidence,suggests,systemically,elevated,blood,levels,may,serve,independent,risk,related,fractures,Taken,together,signaling,potential,therapeutic,target,novel,biomarker,patients
AB值:
0.565432
相似文献
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao;Ding Ma;Yun-Song Yang;Fan Yang;Jia-Han Ding;Yue Gong;Lin Jiang;Li-Ping Ge;Song-Yang Wu;Qiang Yu;Qing Zhang;Francois Bertucci;Qiuzhuang Sun;Xin Hu;Da-Qiang Li;Zhi-Ming Shao;Yi-Zhou Jiang-Key Laboratory of Breast Cancer in Shanghai,Department of Breast Surgery,Fudan University Shanghai Cancer Center;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai,China;Human Phenome Institute,Fudan University,Shanghai,China;Department of Pathology,University of Texas Southwestern Medical Center,Dallas,TX,USA;Predictive Oncology team,Centre de Recherche en Cancérologie de Marseille(CRCM),INSERM UMR1068,CNRS UMR725,Aix-Marseille Université,Institut Paoli-Calmettes,Marseille,France;Department of Industrial Systems Engineering and Management,National University of Singapore,Singapore,Singapore
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。